QCG
IMMU

Quadrant Capital Group’s Immunomedics Inc IMMU Stock Holding History

Quadrant Capital Group’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-728
Closed -$62K – 2430
2020
Q3 		$62K Buy
728
+45
+7% +$2.28K 0.01% 600
2020
Q2 		$24K Buy
683
+112
+20% +$3.27K 0.01% 997
2020
Q1 		$8K Buy
571
+14
+3% +$236 ﹤0.01% 1517
2019
Q4 		$11K Hold
557
– – ﹤0.01% 1880
2019
Q3 		$7K Buy
+557
New +$8.19K ﹤0.01% 1872
2019
Q2 		– Sell
-372
Closed -$7K – 2447
2019
Q1 		$7K Buy
+372
New +$6K ﹤0.01% 1802

Quadrant Capital Group's IMMU Position: Q4 2020 in Review

Quadrant Capital Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 728 shares — an estimated $62K sold.

Quadrant Capital Group first reported a position in IMMU in Q1 2019 and held it in 6 quarters. The position peaked at $62K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Quadrant Capital Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Quadrant Capital Group sold 728 Immunomedics Inc shares in Q4 2020, an estimated $62K.
  • Quadrant Capital Group first reported a position in Immunomedics Inc in Q1 2019 and held it in 6 quarters.
  • Quadrant Capital Group's Immunomedics Inc position peaked at $62K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Quadrant Capital Group's 13F filing for Q4 2020, filed 16 Feb 2021.